VBL Therapeutics is a publicly-traded, clinical-stage biotechnology company committed to the discovery, development, and commercialization of next-generation, targeted medicines for difficult-to-treat medical conditions.

Biotechnology

VBL's headquarters in Modi'in-Maccabim-Re'ut, Israel

Dror Harats

Livnat Bangio

Thomas Herzog

Antonio Casado Herraez

Marc Kozin

Bradley J. Monk

Andrew J. Brenner

Ruth Arnon

Krishnansu S. Tewari

Timothy Cloughesy

Patrick Y. Wen

Rebecca C. Arend

Kathleen Moore

Richard T. Penson

Nicholas Butowski

Ronnie Shapira-Frommer

David Hastings

Michael Rice

Ruth Alon

Shmuel Ben Zvi

Jonathan A. Ledermann

The Research and Development team at VBL Therapeutics focuses on pioneering advanced therapeutic solutions by conducting innovative research, optimizing production processes, and ensuring the effective transition of drug candidates from the laboratory into clinical trials. Comprising a diverse group of scientific advisors and operations specialists, the team collaborates to drive the discovery and development of targeted medicines aimed at addressing challenging medical conditions.

Research and Development

This department focuses on strategic direction and high-level decision-making within the organization.

Leadership

The Leadership Team at VBL Therapeutics is responsible for setting the strategic direction of the company and driving its clinical and operational initiatives. This team, comprising the CEO and senior vice presidents, collaborates to oversee research, development, and commercialization efforts, ensuring that VBL remains at the forefront of innovative treatments for challenging medical conditions. They also focus on resource optimization and stakeholder engagement to achieve the company's long-term goals.

Leadership Team

VBL

Org chart

Board & advisors

Teams

Research and Development

Leadership

Leadership Team

Offices

VBL

Org chart

Board & advisors

Teams

Research and Development

Leadership

Leadership Team

Offices

Related companies